Business & Finance
Bristol Myers Squibb's board authorises dividends on common & preferred stock
18 June 2021 -

The board of directors of Bristol Myers Squibb (NYSE:BMY), a biopharmaceutical company, declared on Thursday its quarterly dividend of USD0.49 per share on the USD0.10 par value common stock.

This dividend is payable on 2 August 2021 to stockholders of record of common stock at the close of business as of 2 July 2021.

Concurrently, the board approved its quarterly dividend of USD0.50 per share on the company's USD2.00 convertible preferred stock.

Stockholders of record of preferred stock at the close of business on 10 August 2021 will receive the dividend on 1 September 2021.